aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, Jinlin Hou, Shuyuan Mo et al.|Journal of Hepatology|2020Cited by 346
Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysisHidenori Toyoda, Yasuhito Tanaka, Takashi Kumada et al.|Journal of Gastroenterology|2016Cited by 76
Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysisHidenori Toyoda, Yasuhito Tanaka, Toshifumi Tada et al.|Journal of Gastroenterology|2016Cited by 60